Medicine & Life Sciences
Sumatriptan
100%
Inhibitory Postsynaptic Potentials
91%
Periaqueductal Gray
90%
Mesencephalon
74%
Synaptic Transmission
67%
serotonin 1F receptor
37%
Serotonin
34%
Migraine Disorders
30%
Serotonin 5-HT1 Receptor Antagonists
29%
L 694247
20%
Inhibitory Concentration 50
18%
Receptor, Serotonin, 5-HT1D
16%
Receptor, Serotonin, 5-HT1B
14%
Serotonin 5-HT1 Receptor Agonists
13%
8-Hydroxy-2-(di-n-propylamino)tetralin
13%
Neurons
12%
Excitatory Postsynaptic Potentials
11%
Fluoxetine
11%
hydroxide ion
11%
Serotonin Uptake Inhibitors
11%
Opioid Analgesics
9%
Neurotransmitter Agents
8%
Analgesics
8%
Real-Time Polymerase Chain Reaction
8%
Ligands
7%
Drug Therapy
6%
Messenger RNA
5%
In Vitro Techniques
4%
Pharmaceutical Preparations
4%